Home › News and Press › Press releases

News and Press releases

View all News Press releases

OXC-101 for AML accepted to be presented at EHA

April 30, 2026 · Press releases

Oxcia AB (publ) publishes interim report for the first quarter 2026

April 22, 2026 · Press releases

Oxcia enters into a new collaboration to investigate pathways linked to lung fibrosis and cough

April 21, 2026 · Press releases

OXC-101 as a novel therapy in canine blood cancer will be presented at AACR

April 20, 2026 · Press releases

Oxcia AB (publ) publishes interim report for the fourth quarter 2025

February 17, 2026 · Press releases

Oxcia welcomes new Scientific Advisory Board for OXC-201

December 29, 2025 · Press releases

Oxcia AB (publ) publishes interim report for the third quarter 2025

October 28, 2025 · Press releases

Oxcia compounds demonstrate antiviral activity

September 9, 2025 · Press releases

Oxcia AB (publ) publishes interim report for the second quarter 2025

August 28, 2025 · Press releases

EMA approves ODD for OXC-101 in AML

August 26, 2025 · Press releases

Scientific progress in Psoriasis Research with OXC-101

August 21, 2025 · Press releases

Potential for OXC-101 as a novel therapy for ovarian cancer

July 15, 2025 · Press releases

Search